Methodology breakdown computing — it will appear here on its own.
Galderma Group AG - ADR (GALDY) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-07-31). See the full ratio breakdown and business-activity screen below for the reasoning.
Computing the full ratio and business-activity breakdown for GALDY — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 30.10 | NEUTRAL |
| Stochastic %K (14) | 2.47 | BUY |
| CCI (20) | -154.41 | BUY |
| Williams %R (14) | -97.53 | BUY |
| MACD (12,26,9) | -0.44 | SELL |
| ROC (10) | -11.15 | SELL |
| Momentum (10) | -4.74 | SELL |
| EMA (10) | 39.51 | SELL |
| SMA (10) | 39.82 | SELL |
| EMA (20) | 40.65 | SELL |
| SMA (20) | 41.11 | SELL |
| EMA (30) | 41.24 | SELL |
| SMA (30) | 41.95 | SELL |
| EMA (50) | 41.71 | SELL |
| SMA (50) | 42.33 | SELL |
| EMA (100) | 41.57 | SELL |
| SMA (100) | 42.11 | SELL |
| EMA (200) | 40.32 | SELL |
| SMA (200) | 40.69 | SELL |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Drug Manufacturers - Specialty & Generic
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Background via Yahoo Finance — informational, not part of the verdict.
🟠 NOT YET
The main driver: lagging the market by 12.4%. More negatives than positives right now. The setup isn't ready — check back when the trend or RSI changes.
Scores: 1 bullish / 2 bearish
No real edge — avoid
| Timeframe | Bias | Bars |
|---|---|---|
| ⏰ 4H | BEARISH | 26 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | RANGING | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-08 · Asset managers net 912361 (-21819)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.